Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | -48.90% |
| 10 | Zimmer Biomet Holdings | 18.07 Bn | 17.64 Bn | 1.51 Bn | -51.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.65% |
| Dec 31, 2025 | -56.88% |
| Sep 30, 2025 | 62.68% |
| Jun 30, 2025 | -168.13% |
| Mar 31, 2025 | 96.57% |
| Dec 31, 2024 | 61.37% |
| Sep 30, 2024 | 47.61% |
| Jun 30, 2024 | -52.89% |
| Mar 31, 2024 | 40.31% |
| Dec 31, 2023 | 34.92% |
| Sep 30, 2023 | -28.00% |
| Jun 30, 2023 | 86.13% |
| Mar 31, 2023 | -26.55% |
| Dec 31, 2022 | -55.65% |
| Sep 30, 2022 | 14.00% |
| Jun 30, 2022 | 38.16% |
| Mar 31, 2022 | 37.78% |
| Dec 31, 2021 | -182.19% |
| Sep 30, 2021 | -63.92% |
| Jun 30, 2021 | 30.64% |